130 related articles for article (PubMed ID: 20371993)
1. [Search for antiamyloidogenic compounds based on a nucleation-dependent polymerization model].
Naiki H; Hasegawa K; Ono K; Yamada M
Yakugaku Zasshi; 2010 Apr; 130(4):503-9. PubMed ID: 20371993
[TBL] [Abstract][Full Text] [Related]
2. The anti-amyloidogenic effect is exerted against Alzheimer's beta-amyloid fibrils in vitro by preferential and reversible binding of flavonoids to the amyloid fibril structure.
Hirohata M; Hasegawa K; Tsutsumi-Yasuhara S; Ohhashi Y; Ookoshi T; Ono K; Yamada M; Naiki H
Biochemistry; 2007 Feb; 46(7):1888-99. PubMed ID: 17253770
[TBL] [Abstract][Full Text] [Related]
3. Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease.
Ono K; Yoshiike Y; Takashima A; Hasegawa K; Naiki H; Yamada M
J Neurochem; 2003 Oct; 87(1):172-81. PubMed ID: 12969264
[TBL] [Abstract][Full Text] [Related]
4. Anti-amyloidogenic activity of tannic acid and its activity to destabilize Alzheimer's beta-amyloid fibrils in vitro.
Ono K; Hasegawa K; Naiki H; Yamada M
Biochim Biophys Acta; 2004 Nov; 1690(3):193-202. PubMed ID: 15511626
[TBL] [Abstract][Full Text] [Related]
5. Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro.
Ono K; Hasegawa K; Naiki H; Yamada M
J Neurosci Res; 2004 Mar; 75(6):742-50. PubMed ID: 14994335
[TBL] [Abstract][Full Text] [Related]
6. The role of phenolic OH groups of flavonoid compounds with H-bond formation ability to suppress amyloid mature fibrils by destabilizing β-sheet conformation of monomeric Aβ17-42.
Andarzi Gargari S; Barzegar A; Tarinejad A
PLoS One; 2018; 13(6):e0199541. PubMed ID: 29953467
[TBL] [Abstract][Full Text] [Related]
7. Inhibitors of amyloid beta-protein aggregation mediated by GM1-containing raft-like membranes.
Matsuzaki K; Noguch T; Wakabayashi M; Ikeda K; Okada T; Ohashi Y; Hoshino M; Naiki H
Biochim Biophys Acta; 2007 Jan; 1768(1):122-30. PubMed ID: 17069749
[TBL] [Abstract][Full Text] [Related]
8. Anti-amyloidogenic effects of soybean isoflavones in vitro: Fluorescence spectroscopy demonstrating direct binding to Aβ monomers, oligomers and fibrils.
Hirohata M; Ono K; Takasaki J; Takahashi R; Ikeda T; Morinaga A; Yamada M
Biochim Biophys Acta; 2012 Aug; 1822(8):1316-24. PubMed ID: 22587837
[TBL] [Abstract][Full Text] [Related]
9. Kinetic modeling and determination of reaction constants of Alzheimer's beta-amyloid fibril extension and dissociation using surface plasmon resonance.
Hasegawa K; Ono K; Yamada M; Naiki H
Biochemistry; 2002 Nov; 41(46):13489-98. PubMed ID: 12427009
[TBL] [Abstract][Full Text] [Related]
10. Polyphenols as potential inhibitors of amyloid aggregation and toxicity: possible significance to Alzheimer's disease.
Bastianetto S; Krantic S; Quirion R
Mini Rev Med Chem; 2008 May; 8(5):429-35. PubMed ID: 18473932
[TBL] [Abstract][Full Text] [Related]
11. Critical role of interfaces and agitation on the nucleation of Abeta amyloid fibrils at low concentrations of Abeta monomers.
Morinaga A; Hasegawa K; Nomura R; Ookoshi T; Ozawa D; Goto Y; Yamada M; Naiki H
Biochim Biophys Acta; 2010 Apr; 1804(4):986-95. PubMed ID: 20100601
[TBL] [Abstract][Full Text] [Related]
12. Preformed beta-amyloid fibrils are destabilized by coenzyme Q10 in vitro.
Ono K; Hasegawa K; Naiki H; Yamada M
Biochem Biophys Res Commun; 2005 Apr; 330(1):111-6. PubMed ID: 15781239
[TBL] [Abstract][Full Text] [Related]
13. Polyphenols Modulate Alzheimer's Amyloid Beta Aggregation in a Structure-Dependent Manner.
Phan HTT; Samarat K; Takamura Y; Azo-Oussou AF; Nakazono Y; Vestergaard MC
Nutrients; 2019 Mar; 11(4):. PubMed ID: 30935135
[TBL] [Abstract][Full Text] [Related]
14. The development of preventives and therapeutics for Alzheimer's disease that inhibit the formation of beta-amyloid fibrils (fAbeta), as well as destabilize preformed fAbeta.
Ono K; Naiki H; Yamada M
Curr Pharm Des; 2006; 12(33):4357-75. PubMed ID: 17105432
[TBL] [Abstract][Full Text] [Related]
15. Walnut extract inhibits the fibrillization of amyloid beta-protein, and also defibrillizes its preformed fibrils.
Chauhan N; Wang KC; Wegiel J; Malik MN
Curr Alzheimer Res; 2004 Aug; 1(3):183-8. PubMed ID: 15975066
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation.
Feng Y; Wang XP; Yang SG; Wang YJ; Zhang X; Du XT; Sun XX; Zhao M; Huang L; Liu RT
Neurotoxicology; 2009 Nov; 30(6):986-95. PubMed ID: 19744518
[TBL] [Abstract][Full Text] [Related]
17. Lipid membranes catalyse the fibril formation of the amyloid-β (1-42) peptide through lipid-fibril interactions that reinforce secondary pathways.
Lindberg DJ; Wesén E; Björkeroth J; Rocha S; Esbjörner EK
Biochim Biophys Acta Biomembr; 2017 Oct; 1859(10):1921-1929. PubMed ID: 28564579
[TBL] [Abstract][Full Text] [Related]
18. Resolution of localized small molecule-Aβ interactions by deep-ultraviolet resonance Raman spectroscopy.
Wang M; Jiji RD
Biophys Chem; 2011 Oct; 158(2-3):96-103. PubMed ID: 21652140
[TBL] [Abstract][Full Text] [Related]
19. Natural Phenolic Compounds as Therapeutic and Preventive Agents for Cerebral Amyloidosis.
Yamada M; Ono K; Hamaguchi T; Noguchi-Shinohara M
Adv Exp Med Biol; 2015; 863():79-94. PubMed ID: 26092627
[TBL] [Abstract][Full Text] [Related]
20. The Properties of Amyloid-β Fibrils Are Determined by their Path of Formation.
Brännström K; Islam T; Gharibyan AL; Iakovleva I; Nilsson L; Lee CC; Sandblad L; Pamrén A; Olofsson A
J Mol Biol; 2018 Jun; 430(13):1940-1949. PubMed ID: 29751013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
